Document is current
Any future updates will be listed below
-
Authors
Ha, Woo-Seok
Nguyen, Vinh Khang
Chu, Min Kyung
-
Funding
Funding for this research was provided by:
Korea Health Industry Development Institute (HV22C0106)
National Research Foundation of Korea (National Research Foundation of Korea (NRF))
- License Information
-
More Information
Article History
Received: 20 August 2024
Accepted: 16 September 2024
First Online: 27 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: WSH serves as junior editor of <i>The Journal of Headache and Pain</i>.
: VKN has no conflicts of interest.
: MKC serves as a board member of <i>The Journal of Headache and Pain</i>. MKC was the site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and the Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and the Ildong Pharmaceutical Company over the past 24 months. He received grants from the Yonsei University College of Medicine (6-2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22C0106), and an NRF grant from the Korean government (MSIT) (2022R1A2C1091767).
